EP1429740A4 - CORE FORMULATION COMPRISING TROGLITAZONE AND BIGUANIDE - Google Patents

CORE FORMULATION COMPRISING TROGLITAZONE AND BIGUANIDE

Info

Publication number: EP1429740A4
Authority: EP; European Patent Office
Prior art keywords: troglitazone; biguanide; core formulation; formulation; core
Prior art date: 2001-07-10
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP01952549A

Other languages

German (de)

French (fr)

Other versions

EP1429740A1 (en

Inventor

Akwete L Adjei

Yaping Zhu

Anthony J Cutie

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Kos Life Sciences Inc

Original Assignee

Kos Life Sciences Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-07-10

Filing date

2001-07-10

Publication date

2005-01-26

2001-07-10 Application filed by Kos Life Sciences Inc filed Critical Kos Life Sciences Inc

2001-07-10 Priority claimed from PCT/US2001/021616 external-priority patent/WO2003005993A1/en

2004-06-23 Publication of EP1429740A1 publication Critical patent/EP1429740A1/en

2005-01-26 Publication of EP1429740A4 publication Critical patent/EP1429740A4/en

Status Withdrawn legal-status Critical Current

Links

EP01952549A 2001-07-10 2001-07-10 CORE FORMULATION COMPRISING TROGLITAZONE AND BIGUANIDE Withdrawn EP1429740A4 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/US2001/021616 WO2003005993A1 (en)	2000-05-01	2001-07-10	Core formulation comprising troglitazone and a biguanide

Publications (2)

Publication Number	Publication Date
EP1429740A1 EP1429740A1 (en)	2004-06-23
EP1429740A4 true EP1429740A4 (en)	2005-01-26

Family

ID=32067644

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP01952549A Withdrawn EP1429740A4 (en)	2001-07-10	2001-07-10	CORE FORMULATION COMPRISING TROGLITAZONE AND BIGUANIDE

Country Status (5)

Country	Link
EP (1)	EP1429740A4 (en)
JP (1)	JP2004536842A (en)
AU (1)	AU2001273290B2 (en)
CA (1)	CA2453782A1 (en)
MX (1)	MXPA04000181A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7785627B2 (en) *	2002-09-20	2010-08-31	Watson Pharmaceuticals, Inc.	Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative

Citations (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1997041842A1 (en) *	1996-05-09	1997-11-13	The Trustees Of The University Of Pennsylvania	Hollow bone mineral-like calcium phosphate particles
US6011049A (en) *	1997-02-19	2000-01-04	Warner-Lambert Company	Combinations for diabetes
WO2000028989A1 (en) *	1998-11-12	2000-05-25	Smithkline Beecham P.L.C.	Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
DE19860699A1 (en) *	1998-12-30	2000-07-06	Hexal Ag	Well tolerated oral antidiabetic agent composition, contains conventional active agent, e.g. glibenclamide, and silicone compound to eliminate need for induction period during therapy
WO2000044681A2 (en) *	1999-02-01	2000-08-03	The Curators Of The University Of Missouri	Method for preparing porous shells or gels from glass particles
WO2001035941A2 (en) *	1999-11-16	2001-05-25	Smithkline Beecham P.L.C.	Novel composition based on a thiazolidinedione and metformin and use
WO2001035940A2 (en) *	1999-11-16	2001-05-25	Smithkline Beecham P.L.C.	Pharmaceutical composition comprising a thiazolidinedione-metformin hydrochloride

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6451342B2 (en) *	2000-05-01	2002-09-17	Aeropharm Technology Incorporated	Core formulation comprised of troglitazone and a biguanide

2001
- 2001-07-10 JP JP2003511800A patent/JP2004536842A/en active Pending
- 2001-07-10 AU AU2001273290A patent/AU2001273290B2/en not_active Ceased
- 2001-07-10 EP EP01952549A patent/EP1429740A4/en not_active Withdrawn
- 2001-07-10 CA CA002453782A patent/CA2453782A1/en not_active Abandoned
- 2001-07-10 MX MXPA04000181A patent/MXPA04000181A/en unknown

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1997041842A1 (en) *	1996-05-09	1997-11-13	The Trustees Of The University Of Pennsylvania	Hollow bone mineral-like calcium phosphate particles
US6011049A (en) *	1997-02-19	2000-01-04	Warner-Lambert Company	Combinations for diabetes
WO2000027401A1 (en) *	1998-11-09	2000-05-18	Warner-Lambert Company	Combinations for diabetes which contain a sulfonylurea, a glitazone and a biguanide
WO2000028989A1 (en) *	1998-11-12	2000-05-25	Smithkline Beecham P.L.C.	Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
DE19860699A1 (en) *	1998-12-30	2000-07-06	Hexal Ag	Well tolerated oral antidiabetic agent composition, contains conventional active agent, e.g. glibenclamide, and silicone compound to eliminate need for induction period during therapy
WO2000044681A2 (en) *	1999-02-01	2000-08-03	The Curators Of The University Of Missouri	Method for preparing porous shells or gels from glass particles
WO2001035941A2 (en) *	1999-11-16	2001-05-25	Smithkline Beecham P.L.C.	Novel composition based on a thiazolidinedione and metformin and use
WO2001035940A2 (en) *	1999-11-16	2001-05-25	Smithkline Beecham P.L.C.	Pharmaceutical composition comprising a thiazolidinedione-metformin hydrochloride

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO03005993A1 *

Also Published As

Publication number	Publication date
CA2453782A1 (en)	2003-01-23
JP2004536842A (en)	2004-12-09
EP1429740A1 (en)	2004-06-23
MXPA04000181A (en)	2004-11-22
AU2001273290B2 (en)	2004-10-07

Publication	Publication Date	Title
EP1298180A4 (en)	2005-03-09	HYDROFUGE AND OLEOFUE COMPOSITION
NO20033384L (en)	2003-09-25	Pharmaceutical Formulation
CY2014009I1 (en)	2015-12-09	PESTICIDE PREPARATION
NO20033785L (en)	2003-10-24	Pharmaceutical formulation
NO20041316L (en)	2004-03-30	Thiophene and thiazoisulfonamides as antineoplastic agents
DK1441587T3 (en)	2006-05-22	pesticide Formulations
NO20035627D0 (en)	2003-12-15	Pharmaceutical formulation
NO20033615L (en)	2003-08-14	Agrochemical formulation
NO20041485L (en)	2004-04-13	Pharmaceutical formulation comprising (R) -bicalutamide
DE60221674D1 (en)	2007-09-20	LYOPHILIZED FORMULATION CONTAINING OLANZAPINE
DK1313370T3 (en)	2004-08-16	Fungicide formulation
DE60100447D1 (en)	2003-08-14	Solid pesticide formulation
DE60220799D1 (en)	2007-08-02	HYPOGLYKEMIC AGENT
EP1429747A4 (en)	2005-01-05	Core formulation comprising pioglitazone hydrochloride and a biguanide
EP1429740A4 (en)	2005-01-26	CORE FORMULATION COMPRISING TROGLITAZONE AND BIGUANIDE
NO20024625D0 (en)	2002-09-26	robot Games
IL147063A0 (en)	2002-08-14	Pesticidal formulation
NO20014350L (en)	2003-03-10	Puzzle
DE60219418D1 (en)	2007-05-24	SILANOLLPHENOL AND NAPHTHOLE
FI20010672L (en)	2002-10-01	Roll handling platform
DE60140770D1 (en)	2010-01-21	FIXING AND INTERMEDIATE ROLLING
NO20041236L (en)	2004-03-24	Pharmaceutical Formulation
FR2850567B1 (en)	2005-03-25	COSMETIC COMPOSITION COMPRISING A CATIONIC HYDROGELIFYING AMIDE AND A SURFACTANT
AU2001273309A1 (en)	2003-01-29	Core formulation comprising troglitazone and a biguanide
SE0100478D0 (en)	2001-02-13	Novel formulation

Legal Events

Date	Code	Title	Description
2004-05-07	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2004-06-23	17P	Request for examination filed	Effective date: 20040109
2004-06-23	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
2004-06-23	AX	Request for extension of the european patent	Extension state: AL LT LV MK RO SI
2005-01-26	A4	Supplementary search report drawn up and despatched	Effective date: 20041210
2005-01-26	RIC1	Information provided on ipc code assigned before grant	Ipc: 7A 61K 9/50 B Ipc: 7A 61K 31/4439 B Ipc: 7A 61K 31/155 B Ipc: 7A 61K 9/16 A
2005-05-11	17Q	First examination report despatched	Effective date: 20050323
2005-09-23	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN
2005-11-09	18W	Application withdrawn	Effective date: 20050912